PDGFRα inhibition in soft-tissue sarcomas: Have we gotten it all wrong?

EBioMedicine. 2019 Feb:40:37-38. doi: 10.1016/j.ebiom.2019.01.062. Epub 2019 Feb 5.

Authors

Andrea Napolitano¹, Bruno Vincenzi²

Affiliations

¹ Medical Oncology, Università Campus Bio-Medico, Rome, Italy.
² Medical Oncology, Università Campus Bio-Medico, Rome, Italy. Electronic address: [email protected].

No abstract available

Publication types

Letter

MeSH terms

Animals
Antineoplastic Agents, Immunological / pharmacology*
Antineoplastic Agents, Immunological / therapeutic use
Disease Models, Animal
Humans
Mice
Molecular Targeted Therapy
Receptor, Platelet-Derived Growth Factor alpha / antagonists & inhibitors
Receptor, Platelet-Derived Growth Factor alpha / metabolism*
Sarcoma / drug therapy
Sarcoma / metabolism*
Sarcoma / mortality
Sarcoma / pathology
Treatment Outcome

Substances

Antineoplastic Agents, Immunological
Receptor, Platelet-Derived Growth Factor alpha